1. FDA warns of possibly severe dental problems from oral, dissolvable buprenorphine

   News item 22 January 2022 Pages: 1 - 1

2. PRAC meeting highlights January 2022

   News item 22 January 2022 Pages: 2 - 2

3. Precaution updates for blonanserin, fingolimod, posaconazole, suvorexant

   News item 22 January 2022 Pages: 3 - 3

4. XELJANZ/XELJANZ XR tofacitinib: risk of MACE, thrombosis, malignancy, infections

   News item 22 January 2022 Pages: 4 - 4

5. In utero statin exposure: risk of preterm birth and low birth weight

   Clinical study 22 January 2022 Pages: 5 - 5

6. Anaplastic lymphoma kinase inhibitor-related psychiatric disorders

   Clinical study 22 January 2022 Pages: 6 - 6

7. COVID-19 vaccines safe in people living with HIV

   Clinical study 22 January 2022 Pages: 7 - 7

8. Fluzone High-dose Quadrivalent: no new safety concerns in US

   Clinical study 22 January 2022 Pages: 8 - 8

9. Pattern of vortioxine AEs generally consistent with those labelled, similar to SSRIs

   Clinical study 22 January 2022 Pages: 9 - 9

10. Sugammadex and neostigmine both comparably safe for reversal of neuromuscular blocks

    Clinical study 22 January 2022 Pages: 10 - 10

11. Transient increase in intussusception after Rotarix vaccination

    Clinical study 22 January 2022 Pages: 11 - 11

12. Use of INN imiglucerase without brand name impacts safety profile

    Unknown 22 January 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 22 January 2022 Pages: 13 - 13

14. Datura stramonium

    Case report 22 January 2022 Pages: 14 - 14

15. Acarbose

    Case report 22 January 2022 Pages: 15 - 15

16. Aciclovir/antibacterials

    Case report 22 January 2022 Pages: 16 - 16

17. Aflibercept/bevacizumab/fluocinolone acetonide

    Case report 22 January 2022 Pages: 17 - 17

18. Alendronic-acid

    Case report 22 January 2022 Pages: 18 - 18

19. Alglucosidase-alfa

    Case report 22 January 2022 Pages: 19 - 19

20. Allopurinol/azathioprine/ciclosporin interaction

    Case report 22 January 2022 Pages: 20 - 20

21. Amikacin/moxifloxacin

    Case report 22 January 2022 Pages: 21 - 21

22. Amisulpride/aripiprazole/carbamazepine

    Case report 22 January 2022 Pages: 22 - 22

23. Amoxicillin/clavulanic-acid/dexamethasone

    Case report 22 January 2022 Pages: 23 - 23

24. Amoxicillin/clavulanic-acid/piperacillin/tazobactam

    Case report 22 January 2022 Pages: 24 - 24

25. Amphotericin-B

    Case report 22 January 2022 Pages: 25 - 26

26. Ampicillin

    Case report 22 January 2022 Pages: 26 - 26

27. Anabolic-steroids/oxandrolone

    Case report 22 January 2022 Pages: 27 - 27

28. Anakinra

    Case report 22 January 2022 Pages: 28 - 28

29. Anti-epileptics

    Case report 22 January 2022 Pages: 29 - 29

30. Antiarrhythmic drugs

    Case report 22 January 2022 Pages: 30 - 30

31. Antibacterials

    Case report 22 January 2022 Pages: 31 - 31

32. Antibacterials/antiepileptic-drugs

    Case report 22 January 2022 Pages: 32 - 32

33. Antibacterials/antineoplastics

    Case report 22 January 2022 Pages: 33 - 33

34. Antidepressants

    Case report 22 January 2022 Pages: 34 - 34

35. Antidepressants/antipsychotics/lithium

    Case report 22 January 2022 Pages: 35 - 35

36. Antidepressants/mirtazapine

    Case report 22 January 2022 Pages: 36 - 36

37. Antidepressants/valproate/zotepine

    Case report 22 January 2022 Pages: 37 - 37

38. Antiepileptic drugs

    Case report 22 January 2022 Pages: 38 - 38

39. Antiepileptics

    Case report 22 January 2022 Pages: 39 - 39

40. Antineoplastics

    Case report 22 January 2022 Pages: 40 - 40

41. Antineoplastics

    Case report 22 January 2022 Pages: 41 - 41

42. Antineoplastics

    Case report 22 January 2022 Pages: 42 - 42

43. Antineoplastics

    Case report 22 January 2022 Pages: 43 - 43

44. Antineoplastics

    Case report 22 January 2022 Pages: 44 - 44

45. Antineoplastics/antirheumatics/mesalazine

    Case report 22 January 2022 Pages: 45 - 45

46. Antineoplastics/folinic acid

    Case report 22 January 2022 Pages: 46 - 46

47. Antipsoriatics/antineoplastics

    Case report 22 January 2022 Pages: 47 - 47

48. Antipsychotics

    Case report 22 January 2022 Pages: 48 - 48

49. Antiretrovirals

    Case report 22 January 2022 Pages: 49 - 49

50. Antithymocyte-globulin/belatacept/mycophenolic-acid

    Case report 22 January 2022 Pages: 50 - 50